Sign in
A Phase 2 Safety and Efficacy Trial of AU-011, a Virus-Like Drug Conjugate, With Dose Escalation and Randomized Masked Expansion in Uveal Melanoma
Prithvi Mruthyunjaya, MD, MHS
Updates from the Field
2021
Comparative Survival of Patients with Posterior Uveal Melanoma Presenting Class 1A Versus Class 1B Gene Expression Profile
Zelia M. Correa, MD, PhD
2018
Gene Expression Profile and Local Tumor Recurrence of Irradiated Uveal Melanomas
Basil K Williams, MD
Annual Meeting Talks
2022
Category: Ocular Oncology